Delanzomib (CEP-18770) in Combination With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma
Clinical trial NCT01348919 · COMPLETED
Trial details
- NCT number
- NCT01348919
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-03
- Primary completion
- 2013-03-14
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.